Zephyrnet Logo

Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy

Date:

Nature Nanotechnology, Published online: 12 August 2021; doi:10.1038/s41565-021-00950-z

Despite its great potential, immune checkpoint blockade has shown efficacy in only a restricted number of patients. In this Article, the authors present a nano-based platform for the co-delivery of chemo- and immunotherapeutics that shows efficient synergic antitumour activity in large, hard-to-treat tumour models.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.nature.com/articles/s41565-021-00950-z

spot_img

Latest Intelligence

spot_img

Chat with us

Hi there! How can I help you?